INCOG BioPharma

INCOG BioPharma's Services

INCOG BioPharma provides comprehensive solutions for drug products from development to commercialization, with a focus on injectable drug products. Their services include formulation, analytical method development, process development, QC chemistry, and microbiology testing. They also offer inspection, labeling, packaging, device assembly, and storage for both materials and finished products. Their consultative approach and customer-focused service ensure that better outcomes are delivered on time and on budget.

INCOG BioPharma's Facilities and Technology

Located in Fishers, Indiana, INCOG BioPharma boasts world-class facilities equipped with state-of-the-art equipment. Their purpose-built processes cater to the global injectable drug product market. Notable technologies include barrier isolation filling and mechanisms such as time pressure and peristaltic pump filling. They also provide non-destructive weight verification inline and ensure zero glass-to-glass contact for syringes and cartridges. The facility handles vial sizes from 2R to 30R, syringes from 0.5 mL to 10 mL, and cartridges from 1.5 mL to 3 mL.

INCOG BioPharma's Industry Recognition

INCOG BioPharma has been recognized as one of Indiana’s Best Places to Work in 2022, 2023, and 2024. This accolade underscores the company's commitment to a positive and productive work environment. Such recognition is indicative of the company's dedication to employee satisfaction and excellence in operations, which likely contributes to their high-quality service offerings and innovative solutions in the biopharmaceutical industry.

INCOG BioPharma's Recent Milestones

INCOG BioPharma has achieved several significant milestones in recent years. They completed the construction of cleanrooms and began manufacturing injectable drug products in Q3 2022. By December 2022, they installed a filling line and sought certification. In February 2024, they expanded their capacity with an additional 100 million units for syringes and cartridges. The grand opening of their state-of-the-art biomanufacturing facility in May 2022 marked another major achievement, highlighting their growth and commitment to advancing biomanufacturing capabilities.

INCOG BioPharma's Collaboration with Resilience

In May 2022, INCOG BioPharma collaborated with Resilience to expedite the manufacturing of biological drug substances and drug products. This partnership aims to leverage INCOG's advanced manufacturing capabilities and Resilience's expertise in biopharmaceutical production to accelerate the delivery of life-saving therapies to the market. Such collaborations are essential in addressing the increasing demand for high-quality biomanufacturing solutions and enhancing the overall efficiency of drug development and commercialization processes.